Antioxidant/oxidant status and cardiac function in bradykinin B1-and B2-Receptor null mice

Physiological Research

Volumn 62, Issue 5, 2013, Pages 511-517

  Delemasure, S ^a   Blaes, N ^d   Richard, C ^b,c   Couture, R ^e   Bader, M ^f   Dutartre, P ^a,b   Girolami, J P ^d   Connat, J L ^a,b   Rochette, L ^a,b  

^a UNIVERSITÉ DE BOURGOGNE   (France)

^b Institut Médical de Génétique et d Immunologie   (France)

^c DIJON UNIVERSITY HOSPITAL   (France)

^d Université de Toulouse   (France)

^e UNIVERSITÉ DE MONTRÉAL   (Canada)

^f MAX DELBRÜCK CENTER FOR MOLECULAR MEDICINE   (Germany)

Author keywords

Doppler; Echocardiography; Kinin receptor; Knockout; Oxidative stress

Indexed keywords

ANTIOXIDANT; BIOLOGICAL MARKER; BRADYKININ B1 RECEPTOR; BRADYKININ B2 RECEPTOR; DEHYDROASCORBIC ACID; DRUG DERIVATIVE; SEMIDEHYDROASCORBIC ACID;

129 MOUSE; ANIMAL; ARTICLE; BLOOD; C57BL MOUSE; DOPPLER ECHOCARDIOGRAPHY; GENETICS; HEART CONTRACTION; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE; KNOCKOUT MOUSE; MALE; METABOLISM; MOUSE; OXIDATIVE STRESS; PATHOPHYSIOLOGY;

ANIMALS; ANTIOXIDANTS; BIOLOGICAL MARKERS; DEHYDROASCORBIC ACID; ECHOCARDIOGRAPHY, DOPPLER, PULSED; MALE; MICE; MICE, 129 STRAIN; MICE, INBRED C57BL; MICE, KNOCKOUT; MYOCARDIAL CONTRACTION; MYOCARDIUM; OXIDATIVE STRESS; RECEPTOR, BRADYKININ B1; RECEPTOR, BRADYKININ B2; VENTRICULAR DYSFUNCTION, LEFT; VENTRICULAR FUNCTION, LEFT;

EID: 84888812825     PISSN: 08628408     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. BHOOLA KD, FIGUEROA CD, WORTHY K: Bioregulation of kinins: kallikreins, kininogens, and kininases. Pharmacol Rev 44: 1-80, 1992.
2. BLAES N, PECHER C, MEHRENBERGER M, CELLIER E, PRADDAUDE F, CHEVALLIER J, TACK I, COUTURE R, GIROLAMI JP: Bradykinin inhibits high glucose-and growth factor-induced collagen synthesis in mesangial cells through the B2-kinin receptor. Am J Physiol Renal Physiol 303: F293-F303, 2012.
3. CAO G, ALESSIO HM, CUTLER RG: Oxygen-radical absorbance capacity assay for antioxydants. Free Radic Biol Med 14: 303-311, 1993.
4. COURDEROT-MASUYER C, LAHET JJ, VERGES B, BRUN J-M, ROCHETTE L: Ascorbyl free radical release in diabetic patients. Cell Mol Biol 46: 1397-1401, 2000.
5. COUTURE R, GIROLAMI J-P: Putative roles of kinin receptors in the therapeutic effects of angiotensin 1-converting enzyme inhibitors in diabetes mellitus. Eur J Pharmacol 500: 467-485, 2004.
6. -/-mice. World J Cardiovasc Dis 2: 184-192, 2012.
7. DIAS JP, COUTURE R: Suppression of vascular inflammation by kinin B1 receptor antagonism in a rat model of insulin resistance. J Cardiovasc Pharmacol 60: 61-69, 2012.
8. DUKA A, KINTSURASHVILI E, DUKA I, ONA D, HOPKINS TA, BADER M, GAVRAS I, GAVRAS H:Angiotensin-converting enzyme inhibition after experimental myocardial infarct: role of the kinin B1 and B2 receptors. Hypertension 51: 1352-1357, 2008.
9. FARBSTEIN D, KOZAK-BLICKSTEIN A, LEVY AP: Antioxidant vitamins and their use in preventing cardiovascular disease. Molecules 15: 8098-8110, 2010.
10. KAYASHIMA Y, SMITHIES O, KAKOKI M: The kallikrein-kinin system and oxidative stress. Curr Opin Nephrol Hypertens 21: 92-96, 2012.
11. LAUTON-SANTOS S, GUATIMOSIM S, CASTRO CH, OLIVEIRA FA, ALMEIDA AP, DIAS-PEIXOTO MF, GOMES MA, PESSOA P, PESQUERO JL, PESQUERO JB, BADER M, CRUZ JS: Kinin B1 receptor participates in the control of cardiac function in mice. Life Sci 81: 814-822, 2007.
12. LEEB-LUNDBERG LM, MARCEAU F, MULLER-ESTERL W, PETTIBONE DJ, ZURAW BL: Classification of the kinin receptor family: from molecular mechanisms to pathophysiological consequences. Pharmacol Rev 57:27-77, 2005.
13. MADEDDU P, VARONI MV, PALOMBA D, EMANUELI C, DEMONTIS MP, GLORIOSO N, DESSI-FULGHERI P, SARZANI R, ANANIA V: Cardiovascular phenotype of a mouse strain with disruption of bradykinin B2-receptor gene. Circulation 96: 3570-3578, 1997.
14. MAESTRI R, MILIA AF, SALIS MB, GRAIANI G, LAGRASTA C, MONICA M, CORRADI D, EMANUELI C, MADEDDU P: Cardiac hypertrophy and microvascular deficit in kinin B2 receptor knockout mice. Hypertension 41: 1151-1155, 2003.
15. OSORIO JC, CHEEMA FH, MARTENS TP, MAHMUT N, KINNEAR C, GONZALES AM, BONNEY W, HOMMA S, LIAO JK, MITAL S: Simvastatin reverses cardiac hypertrophy caused by disruption of the bradykinin 2 receptor. Can J Physiol Pharmacol 86: 633-642, 2008.
16. PESQUERO JB, ARAUJO RC, HEPPENSTALL PA, STUCKI CL, SILVA JA JR, WALTHER T, OLIVEIRA SM, PESQUERO JL, PAIVA AC, CALIXTO JB, LEWIN GR, BADER M: Hypoalgesia and altered inflammatory responses in mice lacking kinin B1 receptors. Proc Natl Acad Sci USA 97: 8140-8145, 2000.
17. POULIOT M, TALBOT S, SENECAL J, DOTIGNY F, VAUCHER E, COUTURE R: Ocular application of the kinin B1 receptor antagonist LF22-0542 inhibits retinal inflammation and oxidative stress in streptozotocin-diabetic rats. PLoS One 7: e33864, 2012.
18. RAM R, MICLELSEN DM, THEODOROPOULOS C, BLAXALL BC: New approaches in small animal echocardiography: imaging the sounds of silence. Am J Physiol Heart Circ Physiol 301: H1765-H1780, 2011.
19. REGOLI D, PLANTE GE, GOBEIL F JR: Impact of kinins in the treatment of cardiovascular diseases. Pharmacol Ther 135: 94-111, 2012.
20. REGOLI D, RIZZI A, PERRON SI, GOBEIL F JR: Classification of kinin receptors. Biol Chem 382: 31-35, 2001.
21. 2-receptor-mediated negative chronotropic effect of bradykinin in canine sinus node. Am J Physiol 265: H876-H879, 1993.
22. TESSIER F, BIRLOUEZ-ARAGON I, TJANI C, GUILLAND J-C: Validation of a micromethod for determining oxidized and reduced vitamin C in plasma by HPLC-fluorescence. Int J Vitam Nutr Res 66: 166-170, 1996.
23. TRABOLD F, PONS S, HAGEGE AA, BLOCH-FAURE M, ALHENC-GELAS F, GIUDICELLI F, RICHERGIUDICELLI C, MENETON P: Cardiovascular phenotypes of kinin B2 receptor-and tissue kallikreindeficient mice. Hypertension 40: 90-95, 2002.
24. VERGELY C, MAUPOIL V, BENDERITTER M, ROCHETTE L: Influence of the severity of myocardial ischemia on the intensity of ascorbyl free radical release and on postischemic recovery during reperfusion. Free Radic Biol Med 24: 470-479, 1998.
25. WENDE AR, SOTO J, OLSEN CD, PIRES KM, SCHELL JC, LARRIEU-LAHARGUE F, LITWIN SE, KAKOKI M, TAKAHASHI N, SMITHIES O, ABEL ED: Loss of bradykinin signaling does not accelerate the development of cardiac dysfunction in type 1 diabetic akita mice. Endocrinology 151: 3536-3342, 2010.
26. WESTERMANN D, WALTHER T, SAVVATIS K, ESCHER F, SOBIREY M, RIAD A, BADER M, SCHULTHEISS HP, TSCHOPE C: Gene deletion of the kinin receptor B1 attenuates cardiac inflammation and fibrosis during the development of experimental diabetic cardiomyopathy. Diabetes 58: 1373-1381, 2009.
27. XU J, CARRETERO OA, SHESELY EG, RHALEB NE, YANG JJ, BADER M, YANG XP: The kinin B1 receptor contributes to the cardioprotective effect of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in mice. Exp Physiol 94: 322-329, 2009.
28. YANG XP, LIU YH, MEHTA D, CAVASIN MA, SHESELY EG, XU J, LIU F, CARRETERO OA: Diminished cardioprotective response to inhibition of angiotensin-converting enzyme and angiotensin II type 1 receptor in B(2) kinin receptor gene knockout mice. Circ Res 88: 1072-1079, 2001.